Table 2.

Cancer related suspicious pathways

Gene Set	P-value	FDR
Mitotic Prometaphase(R)	1.11E-16	4.22E-14
Signaling by Rho GTPases(R)	2.31E-14	4.39E-12
Aurora B signaling(N)	1.81E-11	2.28E-09
PLK1 signaling events(N)	4.92E-11	4.67E-09
Mitotic Metaphase and Anaphase(R)	2.17E-10	1.65E-08
FOXM1 transcription factor network(N)	1.23E-07	7.77E-06
Cell adhesion molecules (CAMs)(K)	1.66E-07	8.96E-06
Hematopoietic cell lineage(K)	1.36E-06	6.34E-05
Staphylococcus aureus infection(K)	1.51E-06	6.34E-05
MHC class II antigen presentation(R)	4.17E-05	9.18E-04